The University of Pennsylvania, Abramson Cancer Center and Division of Hematology-Oncology, Philadelphia, PA, USA.
Fox Chase Cancer Center, Temple University, Philadelphia, PA, USA.
HGG Adv. 2024 Oct 10;5(4):100346. doi: 10.1016/j.xhgg.2024.100346. Epub 2024 Aug 24.
Research participants report interest in receiving genetic research results. How best to return results remains unclear. In this randomized pilot study, we sought to assess the feasibility of returning actionable research results through a two-step process including a patient-centered digital intervention as compared with a genetic counselor (GC) in the Penn Medicine biobank. In Step 1, participants with an actionable result and procedural controls (no actionable result) were invited to digital pre-disclosure education and provided options for opting out of results. In Step 2, those with actionable results who had not opted out were randomized to receive results via a digital disclosure intervention or with a GC. Five participants (2%) opted out of results after Step 1. After both steps, 52 of 113 (46.0%) eligible cases received results, 5 (4.4%) actively declined results, 34 (30.1%) passively declined, and 22 (19.5%) could not be reached. Receiving results was associated with younger age (p < 0.001), completing pre-disclosure education (p < 0.001), and being in the GC arm (p = 0.06). Being older, female, and of Black race were associated with being unable to reach. Older age and Black race were associated with passively declining. Forty-seven percent of those who received results did not have personal or family history to suggest the mutation, and 55.1% completed clinical confirmation testing. The use of digital tools may be acceptable to participants and could reduce costs of returning results. Low uptake, disparities in uptake, and barriers to confirmation testing will be important to address to realize the benefit of returning actionable research results.
研究参与者表示有兴趣接收基因研究结果。但最佳的结果返还方式仍不明确。在这项随机试点研究中,我们试图评估通过两步法(包括患者为中心的数字干预和宾大医学生物库中的遗传咨询师)返还可操作的研究结果的可行性。在步骤 1 中,邀请有可操作结果和程序控制(无可操作结果)的参与者参加数字预披露教育,并提供选择不接收结果的选项。在步骤 2 中,未选择不接收结果的有可操作结果的参与者被随机分配通过数字披露干预或遗传咨询师接收结果。在步骤 1 后,有 5 名(2%)参与者选择不接收结果。在两步之后,113 名符合条件的病例中有 52 名(46.0%)接收了结果,5 名(4.4%)主动拒绝结果,34 名(30.1%)被动拒绝,22 名(19.5%)无法联系到。接收结果与年龄较小(p<0.001)、完成预披露教育(p<0.001)和在遗传咨询师组(p=0.06)相关。年龄较大、女性和黑人种族与无法联系到相关。年龄较大和黑人种族与被动拒绝相关。接收结果的人中,有 47%的人没有个人或家族病史表明突变,55.1%的人完成了临床确认测试。数字工具的使用可能会被参与者接受,并可以降低返还结果的成本。低吸收率、吸收率的差异以及确认测试的障碍将是实现返还可操作研究结果的重要因素。